feed,title,long_url,short_url
Benzinga,"Long-awaited Novavax's COVID-19 Vaccine Results Hit 90% Efficacy In Pivotal US Trial, 100% Efficacy Against Moderate, Severe Infection",https://benzinga.com/general/biotech/21/06/21545400/long-awaited-novavaxs-covid-19-vaccine-results-hit-90-efficacy-in-pivotal-us-trial-100-efficacy-a,https://j.mp/3wnJduR
